NEW YORK (GenomeWeb) – GeneNews today said that its revenues for the third quarter rose around 30-fold year over year.

The Toronto-based molecular diagnostics firm reported total revenues of C$1.1 million (US$973,000) for the three months ended Sept. 30, up from C$37,002 in Q3 2013, according to a regulatory document. All revenues for the recently completed quarter were derived from royalties. In the year-ago period, GeneNews had no royalties.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.